TrialBreast cancer research and treatment2012

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

Jacquie Chirgwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.